Aurélie Rousseau

Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: New and useful markers for pre-eclampsia?

Aurélie Rousseau, Rémi Favier, Patrick Van Dreden · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2009 · 68 citations

Thrombosis, Hypertension, Soluble Thrombomodulin Activity +14

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

Mourad Chaari, Inès Ayadi, Aurélie Rousseau et al. · BMC Cancer · 2014 · 49 citations · Full text

Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia

Pascale Schneider, Patrick Van Dreden, Aurélie Rousseau et al. · British Journal of Haematology · 2009 · 45 citations

Immunology, Blood Cell, Pathology +18

Bayesian Forecasting of Oral Cyclosporin Pharmacokinetics in Stable Lung Transplant Recipients With and Without Cystic Fibrosis

Aurélie Rousseau, Caroline Monchaud, Jean Debord et al. · Therapeutic Drug Monitoring · 2003 · 33 citations

Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

Patrick Van Dreden, Aurélie Rousseau, Arnaud Savouré et al. · Blood Coagulation & Fibrinolysis · 2009 · 32 citations

Heart Failure, Acute Myocardial Infarction, Thrombosis +17